P Gisondi Selected Research

Betamethasone (Celestone)

7/2017

A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Gisondi Research Topics

Disease

47	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 12/2006
5	Psoriatic Arthritis 01/2023 - 03/2012
5	COVID-19 04/2021 - 01/2020
4	Skin Diseases (Skin Disease) 01/2022 - 12/2017
4	Infections 04/2021 - 10/2014
3	Necrosis 01/2021 - 03/2008
3	Obesity 08/2020 - 04/2013
3	Body Weight (Weight, Body) 01/2020 - 03/2008
2	Arthralgia (Joint Pain) 01/2023 - 04/2012
2	Atopic Dermatitis (Atopic Eczema) 01/2023 - 06/2020
2	Hidradenitis Suppurativa 01/2023 - 01/2021
2	Bullous Pemphigoid (Pemphigoid) 01/2023 - 01/2006
2	Chronic Urticaria 01/2023 - 01/2006
2	Rheumatoid Arthritis 01/2023 - 12/2009
2	Hypertension (High Blood Pressure) 01/2013 - 07/2007
1	Melanoma (Melanoma, Malignant) 11/2023
1	Hamartoma 10/2023
1	Localized Scleroderma (Morphea) 10/2023
1	Nevus (Nevi) 10/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Ankylosing Spondylitis 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Injection Site Reaction 01/2023
1	Skin Ulcer 12/2021
1	Virus Diseases (Viral Diseases) 11/2021
1	Pain (Aches) 01/2021
1	Non-alcoholic Fatty Liver Disease 08/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2020
1	Atherosclerotic Plaque (Atheroma) 08/2020
1	Rheumatic Diseases (Rheumatism) 01/2020
1	Joint Diseases (Joint Disease) 04/2018
1	Hepatitis B 11/2017
1	Hepatitis 11/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Anaphylaxis (Anaphylactic Shock) 09/2016
1	Exercise-Induced Allergies 09/2016
1	Solar Urticaria 09/2016

Drug/Important Bio-Agent (IBA)

9	Infliximab (Remicade)FDA Link 01/2020 - 03/2008
6	Adalimumab (Humira)FDA Link 01/2023 - 06/2013
6	Etanercept (Enbrel)FDA Link 12/2019 - 03/2008
4	secukinumabIBA 01/2023 - 12/2017
3	Acitretin FDA Link 01/2019 - 02/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 03/2008
2	Monoclonal AntibodiesIBA 01/2023 - 06/2013
2	Advanced Glycation End ProductsIBA 01/2022 - 01/2022
2	apremilastIBA 01/2021 - 12/2017
2	InterleukinsIBA 08/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
2	Biosimilar PharmaceuticalsIBA 01/2020 - 12/2017
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 03/2008
2	SteroidsIBA 04/2018 - 04/2009
2	AdipokinesIBA 09/2017 - 04/2013
2	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 07/2017 - 06/2015
2	calcipotriene (calcipotriol)FDA LinkGeneric 07/2017 - 06/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2016 - 01/2013
2	Ustekinumab (CNTO 1275)FDA Link 10/2014 - 05/2013
2	C-Reactive ProteinIBA 04/2013 - 10/2010
2	Triglycerides (Triacylglycerol)IBA 04/2013 - 01/2013
2	HomocysteineIBA 10/2010 - 12/2006
2	Folic Acid (Vitamin M)FDA LinkGeneric 10/2010 - 12/2006
1	spesolimabIBA 12/2023
1	trans-crotonin (CTN)IBA 10/2023
1	Abatacept (Orencia)FDA Link 01/2023
1	Omalizumab (Xolair)FDA Link 01/2023
1	Cetuximab (Erbitux)FDA Link 01/2023
1	dupilumabIBA 01/2023
1	evolocumabIBA 01/2023
1	benralizumabIBA 01/2023
1	guselkumabIBA 01/2023
1	Interleukin-4 (Interleukin 4)IBA 01/2023
1	risankizumabIBA 01/2022
1	tildrakizumabIBA 11/2021
1	dimemorfan (AT 17)IBA 03/2021
1	brodalumabIBA 03/2021
1	Prostaglandins AIBA 03/2021
1	Immunomodulating AgentsIBA 01/2021
1	Interleukin-23 (Interleukin 23)IBA 08/2020
1	S100 Calcium Binding Protein A7IBA 01/2020
1	InterferonsIBA 01/2020
1	AntibodiesIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	ixekizumabIBA 01/2019
1	etanercept biosimilar SB4IBA 01/2019
1	CT-P13IBA 12/2017
1	Betamethasone (Celestone)FDA Link 07/2017
1	ElementsIBA 07/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2016
1	Cholinergic Agents (Cholinergics)IBA 09/2016
1	GoldIBA 10/2014

Therapy/Procedure

15	Therapeutics 04/2021 - 03/2008
6	Biological Therapy 06/2021 - 12/2011
1	Precision Medicine 11/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Transplantation 12/2021
1	Immunotherapy 04/2021
1	Subcutaneous Injections 01/2020
1	Injections 04/2018
1	Skin Care 12/2017